Aurinia Pharmaceuticals Inc
Ownership
Ownership Structure
Who owns Aurinia Pharmaceuticals Inc (AUPH)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 97.1% of the shares are freely tradable; institutional investors hold 60.3%.
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 9.80 | 13,044,106 | +6.7 | 06/30/2026 |
| BlackRock Inc | 6.16 | 8,193,085 | +4.4 | 06/30/2026 |
| The Goldman Sachs Group Inc | 4.22 | 5,619,401 | +292.0 | 06/30/2026 |
| NEA Management Company, LLC | 2.98 | 3,969,834 | +0.0 | 06/30/2026 |
| Two Sigma Investments LLC | 2.61 | 3,467,514 | +1.1 | 06/30/2026 |
| Arrowstreet Capital Limited Partnership | 2.45 | 3,264,062 | -0.6 | 06/30/2026 |
| State Street Corp | 1.95 | 2,589,615 | +2.5 | 06/30/2026 |
| Morgan Stanley - Brokerage Accounts | 1.73 | 2,308,244 | +3.4 | 06/30/2026 |
| Marshall Wace Asset Management Ltd | 1.54 | 2,044,007 | +9.0 | 06/30/2026 |
Funds
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| iShares Russell 2000 ETF | 2.32 | 3,089,770 | -1.1 | 09/30/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Insider holdings
| Person | Role | Shares | Value | As of | Type |
|---|---|---|---|---|---|
| Robertson Stephen P. | Chief Legal Officer | 588,848 | 9,480,453 $ | Sep 10, 2026 | direct |
Holdings as of each person's most recent SEC Form 4 filing — excluding options and RSUs, which are not shares yet. Holdings may have changed between two filings.
Insiders
Insider Transactions
| Date | Person | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Sep 10, 2026 | Robertson Stephen P. | Chief Legal Officer | Sell | 11,939 | 15.95 | 190,427 |
| Aug 21, 2026 | Robertson Stephen P. | Chief Legal Officer | Sell | 20,975 | 16.97 | 355,946 |
Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character. View all insider transactions →
Data as of: November 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.